Literature DB >> 24457076

Intercellular adhesion molecule 1/2 and E-selectin in plasma cell mastitis: immunohistochemical study of 35 cases.

Yu Dong1, Jian-Jun Yu2, Yukiko Shibahara3, Huai-Sheng Lu4, Hai-Yan He4, Jian-Dong Liu4, Shi-Fan Chen5, Lin Wang6, Ye Zhang7, Saulo J A Felizola3, Monica S M Chan3, Katsuhiko Ono3, Takanori Ishida8, Noriaki Ohuchi8, Hironobu Sasano9.   

Abstract

Plasma cell mastitis (PCM) is one of the most frequently encountered inflammatory diseases of the nonlactating breast. Histologically, PCM is characterized by infiltration of relatively abundant plasma cells into the mammary ducts. Its pathogenesis has remained unknown. In this study, we immunolocalized intercellular adhesion molecule (ICAM) 1 and 2 and E-selectin, all of which play pivotal roles in the inflammatory process, in 35 cases of PCM. We then compared the results with those of non-PCM and nonpathologic breast tissue. In the ductal epithelium, ICAM-1 immunoreactivity was significantly more pronounced in PCM than in non-PCM (P = .045). Both ICAM-1 (P < .001) and ICAM-2 (P = .001) were significantly more pronounced in PCM than in nonpathologic breast tissue. However, no significant differences in ICAM-2 and E-selectin immunoreactivity were detected between ductal epithelium of PCM and non-PCM. ICAM-1, but not ICAM-2 or E-selectin, demonstrated significantly higher immunoreactivity in endothelial cells of PCM than in nonpathologic breast (P < .001). These results all suggest that ICAM-1 in both ductal epithelium and endothelium plays important roles in the inflammatory process of PCM, possibly through margination, extravasation, and attachment of plasma cells and lymphocytes, which may result in continuous inflammatory cell homing to ductal epithelial cells.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast; Cell adhesion; Inflammation; Plasma cell mastitis

Mesh:

Substances:

Year:  2013        PMID: 24457076     DOI: 10.1016/j.humpath.2013.06.025

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  IL-6/STAT3 signaling pathway is activated in plasma cell mastitis.

Authors:  Yang Liu; Jian Zhang; Yu-Hui Zhou; Yi-Na Jiang; Wei Zhang; Xiao-Jiang Tang; Yu Ren; Shui-Ping Han; Pei-Jun Liu; Jing Xu; Jian-Jun He
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Activation of C3 and C5 May Be Involved in the Inflammatory Progression of PCM and GM.

Authors:  Xiao-Qiang Li; Hong-Guang Sun; Xiao-Hong Wang; Hao-Jie Zhang; Xiang-Sheng Zhang; Yue Yu; Jian Liu; Qing-Qun Guo; Zhen-Lin Yang
Journal:  Inflammation       Date:  2022-01-08       Impact factor: 4.092

Review 3.  Current Understanding and Management of Plasma Cell Mastitis: Can We Benefit from What We Know?

Authors:  Mengying Xing; Shichang Zhang; Xiaoming Zha; Jiexin Zhang
Journal:  Breast Care (Basel)       Date:  2021-10-06       Impact factor: 2.268

4.  Periductal Mastitis: An Inflammatory Disease Related to Bacterial Infection and Consequent Immune Responses?

Authors:  Lu Liu; Fei Zhou; Pin Wang; Lixiang Yu; Zhongbing Ma; Yuyang Li; Dezong Gao; Qiang Zhang; Liang Li; Zhigang Yu
Journal:  Mediators Inflamm       Date:  2017-01-15       Impact factor: 4.711

5.  Chinese herbal compound combined with western medicine therapy in the treatment of plasma cell mastitis: A protocol for systematic review and meta-analysis.

Authors:  Jindan Zhang; Jianzhong Xu; Jiao Zhang; Yun Ren
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.